MPM BioImpact’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,708,582
| Closed | -$9.02M | – | 47 |
|
|
2025
Q1 | $9.02M | Buy |
2,708,582
+34,677
| +1% | +$115K | 1.55% | 29 |
|
|
2024
Q4 | $19.8M | Buy |
2,673,905
+267,191
| +11% | +$1.98M | 2.81% | 11 |
|
|
2024
Q3 | $22.6M | Buy |
2,406,714
+40,000
| +2% | +$376K | 3.39% | 7 |
|
|
2024
Q2 | $19M | Buy |
2,366,714
+166,714
| +8% | +$1.34M | 2.95% | 7 |
|
|
2024
Q1 | $32.6M | Sell |
2,200,000
-1,089,470
| -33% | -$16.1M | 5.24% | 3 |
|
|
2023
Q4 | $26.7M | Buy |
3,289,470
+2,073
| +0.1% | +$16.9K | 6.26% | 2 |
|
|
2023
Q3 | $15M | Buy |
3,287,397
+337,279
| +11% | +$1.53M | 3.99% | 8 |
|
|
2023
Q2 | $20.8M | Buy |
2,950,118
+335,141
| +13% | +$2.36M | 4.18% | 8 |
|
|
2023
Q1 | $16M | Buy |
2,614,977
+465,427
| +22% | +$2.84M | 4.15% | 11 |
|
|
2022
Q4 | $13.7M | Buy |
2,149,550
+449,550
| +26% | +$2.87M | 3.56% | 11 |
|
|
2022
Q3 | $16.3M | Buy |
1,700,000
+500,000
| +42% | +$4.79M | 3.86% | 11 |
|
|
2022
Q2 | $13.2M | Buy |
+1,200,000
| New | +$13.2M | 3.68% | 6 |
|